
Intellia Therapeutics
Price & Volume
Stats
See moreOpen | $9.89 |
Previous Close | $9.86 |
Day Range | $9.68-$10.22 |
52W Range | $7.95-$18.48 |
Market Cap | $1.3B |
Shares Short | 44M |
Financials
See moreRevenue (12 Mos) | $52.8M |
Revenue Growth (YoY) | -48% |
Gross Profit (12 Mos) | -$218M |
Diluted EPS | -$3.35 |
News
See moreYahoo Finance • 14 days ago
Intellia Therapeutics Completes Enrollment in Phase 3 MAGNITUDE-2 Trial of Nexiguran Ziclumeran (Nex-z) for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN)
Yahoo Finance • 30 days ago
Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast
Yahoo Finance • last month
Nike downgraded, Home Depot initiated: Wall Street's top analyst calls
Yahoo Finance • 2 months ago
Cathie Wood Makes Striking Switch Between AI Stock Giants
About
CEO | Dr. John M. Leonard M.D. |
CFO | Mr. Edward J. Dulac III |
Address | 400 Technology Square, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 377 |